Tag: photodynamic therapy industry size

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Photodynamic Therapy Market CAGR Outlook And Future Development#_x000D_

The photodynamic therapy market size has experienced significant expansion over recent years. It is anticipated to increase from $1.53 billion in 2025 to $1.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. Historically, this market’s expansion can be linked to the rising occurrence of skin cancer and precancerous lesions, the increasing preference for minimally invasive therapies, initial positive clinical evaluation of photosensitizers, heightened awareness regarding non-surgical treatment options, and the availability of medical devices utilizing laser technology._x000D_

_x000D_

The photodynamic therapy market is projected to experience robust growth in the near future. It is anticipated to reach $2.04 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period stems from advancements in novel photosensitizer formulations, the broadening of its applications beyond oncology, a rising demand for outpatient therapies, increasing investment in cancer treatment infrastructure, and a growing preference for targeted and precision therapies. Significant trends for the forecast period include the increasing use of photodynamic therapy in oncology, its growing adoption in dermatology and aesthetic treatments, the development of next-generation photosensitizers, a shift towards minimally invasive cancer treatments, and the rising application of combination therapy approaches._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=24731494&type=smp&name=Photodynamic%20Therapy%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Photodynamic Therapy Market Demand Drivers: What’s Powering Industry Growth?#_x000D_

The increasing occurrence of skin cancer is driving expansion in the photodynamic therapy market. Skin cancer stands out as the most frequently diagnosed form of cancer. Despite making up only about 1% of all skin cancers, melanoma is responsible for a significant proportion of fatalities linked to skin cancer. Photodynamic treatment (PDT) involves the application of a light-sensitive drug alongside powerful light to eliminate cancerous cells. A physician applies a lotion containing light-sensitizing chemicals directly to the affected skin cancer site and its adjacent regions. As an illustration, data from Cancer Australia, an Australia-based government agency, revealed that in 2023, around 8,257 fresh diagnoses of melanoma of the skin were made, which represented 2.6% of all cancer-related mortalities. Consequently, the growing incidence of skin cancer is anticipated to stimulate the expansion of the photodynamic therapy market in the foreseeable future._x000D_

_x000D_

#Photodynamic Therapy Market Segment Landscape: Which Areas Lead Development?#_x000D_

The photodynamic therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Drugs, Devices_x000D_

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications_x000D_

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations_x000D_

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems) _x000D_

_x000D_

#Photodynamic Therapy Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_

Leading companies within the photodynamic therapy (PDT) market are increasingly concentrating on conducting clinical trials to assess PDT’s effectiveness when combined with various medications, aiming for superior therapeutic outcomes. Photodynamic therapy itself involves the utilization of light-activated compounds to selectively target and eliminate cancerous or diseased cells. For instance, Kintara Therapeutics, a US-based biotechnology company, initiated a clinical trial in February 2024 for its REM-001 therapy, which targets cutaneous metastatic breast cancer (CMBC). This open-label study (NCT05374915) involves 15 patients and evaluates the second-generation PDT agent REM-001 at a 0.8 mg dose. The trial’s objective is to optimize the study design in advance of a Phase 3 trial, with a focus on the Best Overall Objective Response Rate (bORR) within 24 weeks, and primary endpoints measuring complete and partial responses within the treated fields._x000D_

_x000D_

#Photodynamic Therapy Market Industry Leaders And Competitive Landscape#_x000D_

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc. _x000D_

_x000D_

#View The Full Photodynamic Therapy Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Photodynamic Therapy Market Largest Region By Revenue And Market Share#_x000D_

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Photodynamic Therapy Market Growth Potential: How Will Market Size Change Through 2030?

The photodynamic therapy market has experienced robust expansion in recent years. Its value is projected to rise from $1.53 billion in 2025 to $1.62 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.1%. This historical growth has been driven by several factors, including a higher incidence of skin cancer and precancerous conditions, a growing preference for minimally invasive treatments, early-stage clinical confirmation of photosensitizers, increased public knowledge about non-surgical alternatives, and the widespread availability of laser-based medical equipment.

The market for photodynamic therapy is anticipated to experience substantial expansion over the coming years. By 2030, it is projected to reach a value of $2.04 billion, reflecting a compound annual growth rate (CAGR) of 5.9%. This forecasted growth is driven by innovations in new photosensitizer formulations, broader applications outside of oncology, a growing preference for outpatient procedures, heightened investments in cancer treatment facilities, and an increased focus on targeted and precision-based therapies. Key developments shaping this period involve the broader integration of photodynamic therapy in cancer care, its rising prominence in dermatology and cosmetic treatments, the creation of advanced photosensitizers, a trend toward less invasive cancer interventions, and the increasing adoption of combination treatment strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Photodynamic Therapy Market Expansion Drivers: What Is Shaping Future Growth?

The expansion of the photodynamic therapy market is being driven by the rising incidence of skin cancer. Skin cancer is identified as the most prevalent form of cancer among all types. Although melanoma makes up only about 1% of skin cancer cases, it is responsible for a significant proportion of skin cancer-related fatalities. Photodynamic therapy (PDT) involves using a light-sensitive drug combined with intense light exposure to eliminate cancer cells. A cream containing a light-sensitizing agent is applied by the physician to both the skin cancer lesion and the adjacent area. As an example, Cancer Australia, a governmental agency based in Australia, reported that in 2023, roughly 8,257 new diagnoses of skin melanoma were made, which represented 2.6% of all cancer deaths. Consequently, the growing prevalence of skin cancer is anticipated to boost the photodynamic therapy market in the years ahead.

Photodynamic Therapy Market Segment Outlook: Which Categories Are Expanding The Fastest?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Photodynamic Therapy Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Key players in the photodynamic therapy (PDT) market are placing significant emphasis on clinical research to examine the use of PDT alongside various medications, aiming to improve treatment results. Photodynamic therapy employs light-activated compounds to precisely target and eliminate cancerous or diseased cells. As an example, Kintara Therapeutics, a biotechnology firm headquartered in the US, launched a clinical trial in February 2024 for its REM-001 therapy, designed to treat cutaneous metastatic breast cancer (CMBC). This open-label study (NCT05374915) includes 15 participants and assesses a 0.8 mg dose of the second-generation PDT agent REM-001. The goal is to refine the trial design before proceeding to a Phase 3 study, with a focus on the Best Overall Objective Response Rate (bORR) over 24 weeks, utilizing primary endpoints that gauge both complete and partial reactions within the treated areas.

Photodynamic Therapy Market Key Companies And Competitive Benchmarking

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Access The Complete Photodynamic Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Photodynamic Therapy Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Photodynamic Therapy Market?

The market for photodynamic therapy has experienced significant growth in recent years. It is anticipated to expand from $1.53 billion in 2025 to $1.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. This historical growth can be attributed to several factors including the rising prevalence of skin cancer and precancerous lesions, the increasing use of minimally invasive therapies, early clinical validation of photosensitizers, growing awareness of non-surgical treatment options, and the widespread availability of laser-based medical devices.

The photodynamic therapy market is anticipated to experience robust expansion over the coming years. By 2030, its valuation is projected to reach $2.04 billion, exhibiting a compound annual growth rate (CAGR) of 5.9%. This projected growth is driven by several factors, including innovations in new photosensitizer formulations, the broadening of applications beyond cancer treatment, a heightened need for outpatient medical procedures, increased spending on cancer care facilities, and a rising inclination towards specific and accurate treatment methods. Key developments expected during this period encompass the wider application of photodynamic therapy in cancer care, its increasing use in skin and beauty treatments, the creation of advanced photosensitizers, a move towards less invasive cancer interventions, and an increased embrace of multi-therapy strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Primary Factors Are Fueling The Expansion Of The Photodynamic Therapy Market?

The increasing occurrence of skin cancer is a factor in the expansion of the photodynamic therapy market. Skin cancer is recognized as the most frequently diagnosed cancer among all types. While Melanoma accounts for merely about 1% of skin cancers, it is responsible for a significant proportion of skin cancer fatalities. Photodynamic treatment (PDT) employs a blend of a light-sensitizing drug and highly concentrated light to eliminate cancerous cells. A physician administers a lotion containing a light-sensitizing chemical directly onto the affected skin cancer and its periphery. For example, in 2023, data from Cancer Australia, an Australia-based government agency, indicated that around 8,257 new cases of melanoma of the skin were identified, making up 2.6% of all cancer-related mortalities. Consequently, the growing incidence of skin cancer is anticipated to stimulate the expansion of the photodynamic therapy market in the foreseeable future.

How Is Segment Classification Applied In The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Trends Are Influencing The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy (PDT) market are increasingly prioritizing clinical trials to assess PDT in conjunction with various drugs for improved therapeutic efficacy. Photodynamic therapy utilizes light-activated compounds to specifically target and eliminate cancerous or diseased cells. As an illustration, Kintara Therapeutics, a US-based biotechnology firm, commenced a clinical trial in February 2024 for its REM-001 therapy, which targets cutaneous metastatic breast cancer (CMBC). This open-label investigation (NCT05374915) involves 15 patients and is evaluating the second-generation PDT agent REM-001 at a 0.8 mg dose. The trial seeks to refine the study design in preparation for a Phase 3 trial, concentrating on the Best Overall Objective Response Rate (bORR) within 24 weeks, with its primary endpoints being the measurement of complete and partial responses in the treated areas.

Who Are The Leading Firms Participating In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Access The Complete Photodynamic Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Contributes The Most To The Photodynamic Therapy Market?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Photodynamic Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2026, By The Business Research Company

Photodynamic Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Light Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Laser Photomask Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-photomask-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Photodynamic Therapy Market Between 2026 And 2030?

The photodynamic therapy market has experienced substantial expansion in recent years. Forecasts indicate it will expand from $1.53 billion in 2025 to reach $1.62 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.1%. This historical growth can be primarily linked to several factors, including the increasing occurrence of skin cancer and precancerous lesions, a rise in the adoption of minimally invasive therapies, the early success in clinical validation of photosensitizers, a heightened awareness regarding non-surgical treatment options, and the broader availability of laser-based medical devices.

The photodynamic therapy market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $2.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This projected growth during the forecast period is driven by several factors, including breakthroughs in new photosensitizer formulations, the broadening of applications beyond cancer treatment, an increased need for outpatient care, heightened investment in infrastructure for cancer therapy, and a growing inclination towards targeted and precise treatment methods. Key trends for the forecast period encompass the wider application of photodynamic therapy in oncology, its increased acceptance in dermatology and aesthetic procedures, the creation of advanced photosensitizers, a move towards less invasive cancer treatments, and an increasing reliance on combination therapy strategies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Primary Drivers Are Impacting The Photodynamic Therapy Market Growth?

The increasing incidence of skin cancer is a significant factor driving the expansion of the photodynamic therapy market. Skin cancer is recognized as the most frequently occurring cancer among all types. While melanoma accounts for merely 1% of all skin cancers, it is responsible for a substantial portion of skin cancer-related fatalities. Photodynamic treatment (PDT) functions by utilizing a photosensitizing drug in conjunction with strong light to eliminate cancerous cells. During the procedure, a physician applies a lotion containing a light-sensitive chemical to the affected skin area and its periphery. For example, in 2023, Cancer Australia, a government agency based in Australia, reported approximately 8,257 new diagnoses of melanoma of the skin, which constituted 2.6% of all cancer deaths. Consequently, the rising occurrence of skin cancer is anticipated to propel the growth of the photodynamic therapy market in the forecast period.

How Are Different Segments Classified In The Photodynamic Therapy Market Segment Analysis?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Which Trends Are Guiding The Direction Of The Photodynamic Therapy Market?

Leading companies in the photodynamic therapy (PDT) market are increasingly concentrating on clinical trials to assess PDT in conjunction with various drugs for improved therapeutic results. Photodynamic therapy employs light-activated compounds to selectively identify and eliminate cancerous or diseased cells. For example, in February 2024, Kintara Therapeutics, a US-based biotechnology firm, launched a clinical trial for its REM-001 therapy, targeting cutaneous metastatic breast cancer (CMBC). This open-label study (NCT05374915) involves 15 patients and is evaluating REM-001, a second-generation PDT agent, at a 0.8 mg dose. The trial’s objective is to optimize the study design in preparation for a Phase 3 trial, with a focus on the Best Overall Objective Response Rate (bORR) within 24 weeks, and primary endpoints gauging complete and partial responses in treated regions.

Who Are The Companies Driving Activity In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Get The Full Photodynamic Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Accounts For The Largest Portion Of The Photodynamic Therapy Market?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Photodynamic Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2026, By The Business Research Company

Photodynamic Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Light Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Laser Photomask Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-photomask-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Photodynamic Therapy Market Across 2026–2030?

The photodynamic therapy market has shown robust expansion in recent years. It is forecast to grow from $1.53 billion in 2025 to $1.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. The market’s historical development can be ascribed to factors such as the increasing prevalence of skin cancer and precancerous lesions, a greater embrace of minimally invasive therapies, the initial clinical validation of photosensitizers, an increasing understanding of non-surgical treatment alternatives, and the widespread availability of laser-based medical devices.

The photodynamic therapy market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $2.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This projected growth over the forecast period is fueled by several factors, including breakthroughs in new photosensitizer formulations, the broadening of its applications beyond cancer treatment, an increasing demand for therapies deliverable in outpatient settings, greater investment in infrastructure for cancer treatment, and a growing inclination towards targeted and precise therapeutic methods. Key developments expected during this period involve the greater use of photodynamic therapy in oncology, its increased acceptance in dermatology and aesthetic procedures, the creation of advanced photosensitizers, a move towards less invasive cancer treatments, and an uptick in the adoption of combination therapy approaches.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Market Drivers Are Supporting The Expansion Of The Photodynamic Therapy Market?

The increasing occurrence of skin cancer is contributing to the growth of the photodynamic therapy market. Skin cancer is noted as the most common cancer among all types. Melanoma accounts for only about 1% of skin cancers but is responsible for a significant number of skin cancer deaths. Photodynamic treatment (PDT) involves using a combination of a light-sensitizing medication and intense light to destroy cancer cells. A doctor applies a lotion containing light-sensitizing chemicals to the skin cancer and the surrounding region. For instance, in 2023, data from Cancer Australia, an Australia-based government agency, showed approximately 8,257 new cases of melanoma of the skin were diagnosed, making up 2.6% of all deaths from cancer. Therefore, the rising incidence of skin cancer is expected to drive the growth of the photodynamic therapy market in the foreseeable future.

What Segmentation Levels Are Considered In The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Trends Are Projected To Affect The Photodynamic Therapy Market?

Leading companies within the photodynamic therapy (PDT) market are increasingly dedicating efforts to clinical trials aimed at assessing PDT in combination with various medications for improved therapeutic results. Photodynamic therapy itself involves employing compounds activated by light to specifically target and eliminate cancerous or diseased cells. As an illustration, Kintara Therapeutics, a US-based biotechnology firm, commenced a clinical trial in February 2024 for its REM-001 therapy, which targets cutaneous metastatic breast cancer (CMBC). This open-label study, identified as NCT05374915, involves 15 patients and evaluates REM-001, a second-generation PDT agent, at a 0.8 mg dose. The trial’s objective is to refine the study design prior to a Phase 3 trial, emphasizing the Best Overall Objective Response Rate (bORR) within 24 weeks, with primary endpoints assessing complete and partial responses in the treated areas.

Which Leading Firms Are Contributing To The Growth Of The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Read the full photodynamic therapy market report here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Is The Photodynamic Therapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Photodynamic Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2026, By The Business Research Company

Photodynamic Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Light Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Laser Photomask Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-photomask-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Photodynamic Therapy Market Across 2026–2030?

The photodynamic therapy market has shown robust expansion in recent years. It is forecast to grow from $1.53 billion in 2025 to $1.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. The market’s historical development can be ascribed to factors such as the increasing prevalence of skin cancer and precancerous lesions, a greater embrace of minimally invasive therapies, the initial clinical validation of photosensitizers, an increasing understanding of non-surgical treatment alternatives, and the widespread availability of laser-based medical devices.

The photodynamic therapy market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $2.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This projected growth over the forecast period is fueled by several factors, including breakthroughs in new photosensitizer formulations, the broadening of its applications beyond cancer treatment, an increasing demand for therapies deliverable in outpatient settings, greater investment in infrastructure for cancer treatment, and a growing inclination towards targeted and precise therapeutic methods. Key developments expected during this period involve the greater use of photodynamic therapy in oncology, its increased acceptance in dermatology and aesthetic procedures, the creation of advanced photosensitizers, a move towards less invasive cancer treatments, and an uptick in the adoption of combination therapy approaches.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Market Drivers Are Supporting The Expansion Of The Photodynamic Therapy Market?

The increasing occurrence of skin cancer is contributing to the growth of the photodynamic therapy market. Skin cancer is noted as the most common cancer among all types. Melanoma accounts for only about 1% of skin cancers but is responsible for a significant number of skin cancer deaths. Photodynamic treatment (PDT) involves using a combination of a light-sensitizing medication and intense light to destroy cancer cells. A doctor applies a lotion containing light-sensitizing chemicals to the skin cancer and the surrounding region. For instance, in 2023, data from Cancer Australia, an Australia-based government agency, showed approximately 8,257 new cases of melanoma of the skin were diagnosed, making up 2.6% of all deaths from cancer. Therefore, the rising incidence of skin cancer is expected to drive the growth of the photodynamic therapy market in the foreseeable future.

What Segmentation Levels Are Considered In The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Trends Are Projected To Affect The Photodynamic Therapy Market?

Leading companies within the photodynamic therapy (PDT) market are increasingly dedicating efforts to clinical trials aimed at assessing PDT in combination with various medications for improved therapeutic results. Photodynamic therapy itself involves employing compounds activated by light to specifically target and eliminate cancerous or diseased cells. As an illustration, Kintara Therapeutics, a US-based biotechnology firm, commenced a clinical trial in February 2024 for its REM-001 therapy, which targets cutaneous metastatic breast cancer (CMBC). This open-label study, identified as NCT05374915, involves 15 patients and evaluates REM-001, a second-generation PDT agent, at a 0.8 mg dose. The trial’s objective is to refine the study design prior to a Phase 3 trial, emphasizing the Best Overall Objective Response Rate (bORR) within 24 weeks, with primary endpoints assessing complete and partial responses in the treated areas.

Which Leading Firms Are Contributing To The Growth Of The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Read the full photodynamic therapy market report here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Is The Photodynamic Therapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Photodynamic Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2026, By The Business Research Company

Photodynamic Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Light Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Laser Photomask Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-photomask-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Photodynamic Therapy Market Across 2026–2030?

The photodynamic therapy market has shown robust expansion in recent years. It is forecast to grow from $1.53 billion in 2025 to $1.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.1%. The market’s historical development can be ascribed to factors such as the increasing prevalence of skin cancer and precancerous lesions, a greater embrace of minimally invasive therapies, the initial clinical validation of photosensitizers, an increasing understanding of non-surgical treatment alternatives, and the widespread availability of laser-based medical devices.

The photodynamic therapy market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $2.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This projected growth over the forecast period is fueled by several factors, including breakthroughs in new photosensitizer formulations, the broadening of its applications beyond cancer treatment, an increasing demand for therapies deliverable in outpatient settings, greater investment in infrastructure for cancer treatment, and a growing inclination towards targeted and precise therapeutic methods. Key developments expected during this period involve the greater use of photodynamic therapy in oncology, its increased acceptance in dermatology and aesthetic procedures, the creation of advanced photosensitizers, a move towards less invasive cancer treatments, and an uptick in the adoption of combination therapy approaches.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Market Drivers Are Supporting The Expansion Of The Photodynamic Therapy Market?

The increasing occurrence of skin cancer is contributing to the growth of the photodynamic therapy market. Skin cancer is noted as the most common cancer among all types. Melanoma accounts for only about 1% of skin cancers but is responsible for a significant number of skin cancer deaths. Photodynamic treatment (PDT) involves using a combination of a light-sensitizing medication and intense light to destroy cancer cells. A doctor applies a lotion containing light-sensitizing chemicals to the skin cancer and the surrounding region. For instance, in 2023, data from Cancer Australia, an Australia-based government agency, showed approximately 8,257 new cases of melanoma of the skin were diagnosed, making up 2.6% of all deaths from cancer. Therefore, the rising incidence of skin cancer is expected to drive the growth of the photodynamic therapy market in the foreseeable future.

What Segmentation Levels Are Considered In The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Trends Are Projected To Affect The Photodynamic Therapy Market?

Leading companies within the photodynamic therapy (PDT) market are increasingly dedicating efforts to clinical trials aimed at assessing PDT in combination with various medications for improved therapeutic results. Photodynamic therapy itself involves employing compounds activated by light to specifically target and eliminate cancerous or diseased cells. As an illustration, Kintara Therapeutics, a US-based biotechnology firm, commenced a clinical trial in February 2024 for its REM-001 therapy, which targets cutaneous metastatic breast cancer (CMBC). This open-label study, identified as NCT05374915, involves 15 patients and evaluates REM-001, a second-generation PDT agent, at a 0.8 mg dose. The trial’s objective is to refine the study design prior to a Phase 3 trial, emphasizing the Best Overall Objective Response Rate (bORR) within 24 weeks, with primary endpoints assessing complete and partial responses in the treated areas.

Which Leading Firms Are Contributing To The Growth Of The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Read the full photodynamic therapy market report here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Is The Photodynamic Therapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Photodynamic Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2026, By The Business Research Company

Photodynamic Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Light Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Laser Photomask Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-photomask-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the photodynamic therapy market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Photodynamic Therapy Market be in 2030 compared with 2026?

The photodynamic therapy market size has experienced substantial growth in recent years. It is anticipated to increase from $1.53 billion in 2025 to $1.62 billion in 2026, registering a compound annual growth rate (CAGR) of 6.1%. The expansion observed in the historical period can be ascribed to the escalating prevalence of skin cancer and precancerous lesions, the increased adoption of minimally invasive therapies, the early clinical validation of photosensitizers, rising awareness of non-surgical treatment options, and the accessibility of laser-based medical devices.

The photodynamic therapy market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This anticipated growth during the forecast period is primarily driven by several factors, including developments in new photosensitizer formulations, the broadening of applications beyond cancer treatment, a surge in demand for therapies delivered on an outpatient basis, increased funding for cancer treatment infrastructure, and a growing inclination towards targeted and precise therapeutic approaches. Key trends expected in this period encompass the wider use of photodynamic therapy within oncology, increased acceptance in dermatological and cosmetic procedures, the creation of advanced photosensitizers, a move towards less invasive cancer treatments, and the growing application of combination therapy strategies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Drivers Are Guiding Growth Patterns In The Photodynamic Therapy Market?

The increasing incidence of skin cancer is driving expansion within the photodynamic therapy market. Skin cancer is recognized as the most prevalent type among all cancers. Although melanoma accounts for merely 1% of skin cancers, it is responsible for a significant proportion of fatalities related to skin cancer. Photodynamic treatment (PDT) employs a blend of light-sensitizing medicine and highly intense light to eliminate malignant cells. Physicians apply a lotion containing light-sensitizing chemicals to the affected skin cancer site and its adjacent regions. As an illustration, in 2023, data from Cancer Australia, an Australia-based government body, indicated that around 8,257 new instances of skin melanoma were identified, representing 2.6% of all cancer-related deaths. Consequently, the growing occurrence of skin cancer is anticipated to propel the expansion of the photodynamic therapy market in the foreseeable future.

Which Segments Are Driving Activity In The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Industry Trends Are Transforming The Photodynamic Therapy Market?

Major companies operating within the photodynamic therapy (PDT) market are increasingly focusing on clinical trials to evaluate PDT in combination with different drugs for enhanced therapeutic outcomes. Photodynamic therapy involves using light-activated compounds to selectively target and destroy cancerous or diseased cells. For instance, in February 2024, Kintara Therapeutics, a US-based biotechnology company, initiated a clinical trial for its REM-001 therapy targeting cutaneous metastatic breast cancer (CMBC). This open-label study, identified as NCT05374915, involves 15 patients and evaluates the second-generation PDT agent REM-001 at a 0.8 mg dose. The trial aims to optimize study design ahead of a Phase 3 trial, focusing on the Best Overall Objective Response Rate (bORR) within 24 weeks, with primary endpoints measuring complete and partial responses in treated fields.

Which Key Players Are Driving Competition In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market are Galderma S.A., Bausch Health, Lumenis Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Hologic Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de Produtos Farmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Is Projected To Lead The Photodynamic Therapy Market During The Forecast Period?

North America was the largest region in the photodynamic therapy market in 2025. The regions covered in the photodynamic therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Photodynamic Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2026, By The Business Research Company

Photodynamic Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Light Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/light-therapy-global-market-report

Laser Photomask Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-photomask-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the photodynamic therapy market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Photodynamic Therapy Market Be Worth By 2029, And What CAGR Will It Achieve?

The photodynamic therapy market has experienced robust expansion in recent years. Its value is expected to increase from $1.45 billion in 2024 to $1.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%. This past growth can be ascribed to an aging population pool, a rise in cancer prevalence, an increase in skin diseases, escalating pollution rates, heightened healthcare expenditure, and an expansion in the number of healthcare facilities.

The photodynamic therapy market is anticipated to show considerable expansion over the next few years. It is expected to grow to $1.93 billion in 2029, achieving a compound annual growth rate (CAGR) of 6.0%. The expansion during this forecast period can be linked to factors such as increased healthcare spending, greater insurance coverage for photodynamic therapy, significant opportunities in emerging economies, a rise in the teenage population, an increase in the older population, the growing occurrence of cancer and chronic diseases, and the emergence of infectious illnesses. Prominent trends for the forecast period include the introduction of portable photodynamic therapy devices that facilitate at-home dermatological PDT treatments, investments in artificial intelligence-enabled PDT to enhance patient care, the broadening of product offerings in cosmetic procedures, continued dedication to research and development, an emphasis on providing photoimmunotherapy devices, and the expansion of the portfolio to incorporate photothermal therapy.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Factors Are Driving The Photodynamic Therapy Market Forward?

The growing occurrence of skin cancer is a significant factor driving the expansion of the photodynamic therapy market. Among all types of cancer, skin cancer is recognized as the most frequently diagnosed. While melanoma accounts for merely about 1% of skin cancer cases, it is responsible for a substantial portion of fatalities from skin cancer. Photodynamic treatment (PDT) involves using a photosensitizing drug in conjunction with strong light to eliminate cancerous cells. A clinician applies a lotion containing light-sensitizing chemicals directly to the affected skin cancer area and its periphery. As an illustration, data from January 2024, published by the American Cancer Society, a professional organization based in the U.S., indicates that skin cancer remains the most widespread cancer in the U.S. Here, melanoma, despite making up about 1% of cases, causes most skin cancer deaths. Furthermore, for the year 2024, projections suggest that 100,640 new melanoma diagnoses will occur in the U.S., broken down into around 59,170 cases among men and 41,470 among women. Approximately 8,290 melanoma-related deaths are anticipated, comprising about 5,430 men and 2,860 women. Consequently, the escalating incidence of skin cancer is predicted to stimulate the expansion of the photodynamic therapy market in the foreseeable future.

Which Segments Form The Key Structure Of The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Strategic Shifts And Innovations Are Influencing The Photodynamic Therapy Market?

In the photodynamic therapy market, companies are increasingly directing their efforts towards clinical trials that investigate PDT in conjunction with diverse pharmaceutical agents. Illustratively, in February 2024, Kintara Therapeutics, an American biotechnology enterprise, announced the commencement of a clinical trial for its REM-001 therapy, which targets cutaneous metastatic breast cancer. This particular clinical trial, registered as NCT05374915, is an open-label study featuring 15 patients diagnosed with cutaneous metastatic breast cancer (CMBC), examining the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial’s purpose is to optimize its design in preparation for a subsequent Phase 3 trial, emphasizing the Best Overall Objective Response Rate (bORR) in treatment areas within a 24-week period. The primary endpoint for the trial includes the assessment of both complete and partial responses.

Which Firms Are Making The Biggest Impact In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Is Expected To Lead The Photodynamic Therapy Market In The Next Few Years?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Photodynamic Therapy Market By 2029?

The photodynamic therapy market has experienced significant expansion in recent years. Its value is projected to rise from $1.45 billion in 2024 to $1.53 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.6%. This historical development can be ascribed to factors such as an aging population pool, an increase in cancer prevalence, an increase in skin diseases, rising pollution rates, increased healthcare expenditure, and growth in the number of healthcare facilities.

The photodynamic therapy market is projected to experience robust expansion over the coming years, reaching “$1.93 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.0%. This expansion during the projected timeframe is fueled by several factors, including increased spending on healthcare, broader insurance coverage for photodynamic therapy, significant opportunities within developing nations, a growing adolescent demographic, an expanding elderly population, the rising incidence of cancer and chronic ailments, and the appearance of new infectious diseases. Key developments anticipated for the forecast period encompass the introduction of portable photodynamic therapy devices enabling home-based dermatological PDT applications, investments in AI-powered PDT to enhance patient treatment outcomes, diversification of product offerings for cosmetic procedures, sustained commitment to research and development, and an emphasis on delivering photoimmunotherapy devices while also broadening the portfolio to incorporate photothermal therapy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Drivers Are Shaping The Photodynamic Therapy Industry’s Market Share?

The increasing incidence of skin cancer is propelling the expansion of the photodynamic therapy market. Skin cancer is recognized as the most prevalent type of cancer among all cancers. While melanoma accounts for only about 1% of skin cancers, it is responsible for a significant number of skin cancer fatalities. Photodynamic treatment (PDT) works by utilizing a combination of a light-sensitizing medication and intense light to eradicate cancer cells. A medical professional applies a lotion containing a light-sensitizing chemical to the skin cancer and its surrounding region. For instance, in January 2024, data from the American Cancer Society, a US-based professional organization company, indicated that skin cancer is the most widespread cancer in the U.S., with melanoma representing about 1% of cases yet causing the majority of skin cancer deaths. Furthermore, in 2024, an estimated 100,640 new melanoma cases are expected to be diagnosed in the U.S., comprising approximately 59,170 among men and 41,470 among women. Roughly 8,290 deaths from melanoma are projected, including about 5,430 men and 2,860 women. Therefore, the growing prevalence of skin cancer is anticipated to stimulate the growth of the photodynamic therapy market in the foreseeable future.

Which Key Segments Fueling The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Which Competitive Trends Are Defining The Photodynamic Therapy Market Structure?

Companies within the photodynamic therapy market are increasingly directing their efforts towards clinical trials, particularly those involving PDT combined with various pharmaceutical agents. As an example, in February 2024, Kintara Therapeutics, a biotechnology firm based in the US, disclosed the commencement of a clinical trial for its REM-001 therapy, which is intended for treating cutaneous metastatic breast cancer. This particular clinical trial, identified as NCT05374915, is structured as an open-label investigation. It includes 15 patients afflicted with cutaneous metastatic breast cancer (CMBC) and assesses the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The primary goal of this trial is to refine the study’s framework in preparation for a subsequent Phase 3 trial, with a key emphasis on the Best Overall Objective Response Rate (bORR) observed in treated areas within a 24-week period. Measurement of both complete and partial responses constitutes the primary endpoint.

Which Key Players Are Driving Competition In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Do Regional Market Performances Compare Within The Photodynamic Therapy Industry?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Photodynamic Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model